237 related articles for article (PubMed ID: 6810836)
1. [The renin-angiotensin system and the sympathetic nervous system in essential hypertension].
Vincent M; Milon H; Revol T; Annat G; Froment A; Sassard J; Cier JF
Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():91-4. PubMed ID: 6810836
[TBL] [Abstract][Full Text] [Related]
2. [Age-related changes in the renin-angiotensin-aldosterone system and the sympathetic nervous system in patients with essential hypertension].
Nami R; Martinelli M; Panza F; Pavese G; Carletti F; Buracchi P; Lucani B; Pazzaglia A; Saia F; Gennari C
Minerva Cardioangiol; 1993 Sep; 41(9):387-95. PubMed ID: 8259235
[TBL] [Abstract][Full Text] [Related]
3. Sympathetic activity in borderline and established hypertension in the elderly.
Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB
J Hypertens Suppl; 1988 Nov; 6(1):S55-8. PubMed ID: 3063795
[TBL] [Abstract][Full Text] [Related]
4. The effects of genetic factors on selected indicators of the activity of the sympathoadrenal system and the renin-angiotensin-aldosterone system in twins.
Jedrusik P; Januszewicz A; Busjahn A; Wocial B; Ignatowska-Switalska H; Strelau J; C Luft F; Januszewicz W
Kardiol Pol; 2004 Nov; 61(11):423-9; discussion 430. PubMed ID: 15883590
[TBL] [Abstract][Full Text] [Related]
5. Role of epinephrine in the development of essential hypertension.
Cerasola G; Cottone S; D'Ignoto G; Grasso L; Contorno A; Carone MB; Fulantelli MA
J Clin Hypertens; 1987 Dec; 3(4):670-80. PubMed ID: 3453396
[TBL] [Abstract][Full Text] [Related]
6. Influence of age on orthostatic changes in plasma renin activity and urinary catecholamines in man.
Horký K; Marek J; Kopecká J; Gregorová I
Physiol Bohemoslov; 1975; 24(6):481-8. PubMed ID: 128010
[TBL] [Abstract][Full Text] [Related]
7. Interrelations between plasma renin activity, aldosterone, and sympathetic nervous system activity in essential hypertension.
Jindra A; Ripka O; Savlíková J; Peleska J; Linhartová J; Ort J
Acta Biol Med Ger; 1978; 37(10):1543-50. PubMed ID: 752207
[TBL] [Abstract][Full Text] [Related]
8. [Renin-angiotensin-aldosterone system with regard to age].
Zakharieva S; Ankov V
Vutr Boles; 1982; 21(4):70-5. PubMed ID: 6755912
[TBL] [Abstract][Full Text] [Related]
9. Catecholamines, sodium and renin in unilateral renal hypertension in man.
Weidmann P; Schiffl H; Ziegler WH; Glück Z; Meier A; Keusch G
Miner Electrolyte Metab; 1982 Feb; 7(2):97-112. PubMed ID: 6763143
[TBL] [Abstract][Full Text] [Related]
10. Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension.
Chobanian AV; Gavras H; Melby JC; Gavras I; Jick H
Trans Assoc Am Physicians; 1978; 91():368-80. PubMed ID: 754399
[TBL] [Abstract][Full Text] [Related]
11. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
[TBL] [Abstract][Full Text] [Related]
12. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
[TBL] [Abstract][Full Text] [Related]
13. Age and the renin-aldosterone system.
Noth RH; Lassman MN; Tan SY; Fernandez-Cruz A; Mulrow PJ
Arch Intern Med; 1977 Oct; 137(10):1414-7. PubMed ID: 921422
[TBL] [Abstract][Full Text] [Related]
14. [Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives].
Vetter H; Zumkley H; Glänzer K; Witassek F; Wollnik S; Vetter W
Schweiz Med Wochenschr; 1980 Dec; 110(50):1938-41. PubMed ID: 7010579
[TBL] [Abstract][Full Text] [Related]
15. The multiple factors affecting plasma renin activity in essential hypertension.
McDonald RH; Corder CN; Vagnucci AH; Shuman J
Arch Intern Med; 1978 Apr; 138(4):557-61. PubMed ID: 637637
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin-aldosterone system, RR interval, and blood pressure variability during postural changes in borderline arterial hypertension.
Duprez DA; De Sutter JH; De Buyzere ML; Rietzschel ER; Rimbaut S; Kaufman JM; Van Hoecke MJ; Clement DL
Am J Hypertens; 1995 Jul; 8(7):683-8. PubMed ID: 7546493
[TBL] [Abstract][Full Text] [Related]
17. Renin-angiotensin-aldosterone system in arterial hypertension.
Horký K; Gregorová I
Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018
[TBL] [Abstract][Full Text] [Related]
18. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis.
Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M
Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031
[TBL] [Abstract][Full Text] [Related]
19. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
van den Born BJ; Koopmans RP; van Montfrans GA
Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
[TBL] [Abstract][Full Text] [Related]
20. Quinapril ACE-inhibition effects on adrenergic parameters in moderate essential hypertension.
Vallès Prats M; Matas Serra M; Bronsoms Artero J; Matè Benito G; Torguet Escuder P; Mauri Nicolas JM
Kidney Int Suppl; 1996 Jun; 55():S104-6. PubMed ID: 8743525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
